MammoStar™ STAR1401Recalls & reported problems
Carbon Medical Technologies, Inc. · Biopsy Site Identifier · Class 2 · Implant
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00858015005424), received between Mar 23, 2020 and May 27, 2024 — classified as 3 injuries, 1 malfunction.
The most frequently reported specific device problem is “Patient-Device Incompatibility” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Patient-Device Incompatibility2
- Adverse Event Without Identified Device or Use Problem1
- Failure to Advance1
Patient problems
- Hypersensitivity/Allergic reaction1
- Local Reaction1
- No Known Impact Or Consequence To Patient1
- Unspecified Infection1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryMay 27, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A RETROSPECTIVE CHART REVIEW POST MARKET CLINICAL FOLLOW-UP STUDY REPORTED THAT AN INFECTION WAS OBSERVED WITH A PROBABLE ASSOCIATION. CLINICAL MANAGEMENT INCLUDED TOPICAL MEDICATION, PATIENT OUTCOME IS UNKNOWN. THE PROCEDURE WAS CARRIED OUT DESPITE THE PRESENCE OF AN INFECTION, WHICH IS A KNOWN RISK FACTOR.
Patient problems: Unspecified Infection
MAUDE report 19399290 ↗InjuryMay 27, 2024Patient-Device Incompatibility; Patient-Device Incompatibility
A RETROSPECTIVE CHART REVIEW POST MARKET CLINICAL FOLLOW-UP STUDY REPORTED THAT AN IMMUNE RESPONSE WAS OBSERVED WITH A CAUSAL ASSOCIATION. CLINICAL MANAGEMENT INCLUDED TOPICAL MEDICATION RESULTING IN A FULL RECOVERY. THE PROCEDURE WAS CARRIED OUT DESPITE THE PRESENCE OF AN INFECTION, WHICH IS A KNOWN RISK FACTOR. DESPITE A WARNING IN THE IFU, THE MARKER WAS INSERTED INTO A BLOOD VESSEL.
Patient problems: Hypersensitivity/Allergic reaction
MAUDE report 19399287 ↗InjuryMay 23, 2024Patient-Device Incompatibility; Patient-Device Incompatibility
A RETROSPECTIVE CHART REVIEW POST MARKET CLINICAL FOLLOW-UP STUDY REPORTED THAT HYPERSENSITIVITY WAS OBSERVED WITH A PROBABLY ASSOCIATION TO THE DEVICE OR PROCEDURE. CLINICAL MANAGEMENT WAS NOT REPORTED RESULTING IN A PARTIAL RECOVERY. IT WAS ALSO NOTED THAT THE PROCEDURE WAS CARRIED OUT DESPITE THE PRESENCE OF AN INFECTION, WHICH IS A KNOWN RISK FACTOR.
Patient problems: Local Reaction
MAUDE report 19387896 ↗MalfunctionMar 23, 2020Failure to Advance
DEVICE FAILED TO DEPLOY AS INTENDED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9864743 ↗
Other Marker, Radiographic, Implantable devices
- BioZorb F0202Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls192 reports
- BioZorb F0221Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE3 recalls15 reports
- BioZorb F0203Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls51 reports
- BioZorb F0231Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0304Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0303Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls19 reports
- BioZorb F0404Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls6 reports
- BioZorb F0331Hologic, Inc. · MARKER, RADIOGRAPHIC, IMPLANTABLE2 recalls4 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.